triumph-1 retatrutide TRIUMPH-4. Retatrutide. A once-weekly triple agonist GIP + GLP-1 + glucagon. One molecule. Three switches. 28.7% body weight loss at 68 weeks. ~71 lbs gone. Knee pain down 75.8%. Systolic BP down TRIUMPH-1 Trial Results: Retatrutide for

Tirzepatide takes it a step further by activating both GLP-1 and GIP receptors, making it even more effective in reducing hunger and improving insulin response, which can lead to greater weight loss results

Retatrutide's design positions it as a research tool for investigating how integrated multi-receptor engagement produces effects distinct from single or dual engagement

Weve documented real growth in women and men alike in as little of two months

2016 updated EULAR evidence-based recommendations for the management of gout

Although the exact mechanism is still being studied, multiple factors appear to contribute